Put New Aimovig for Migraine Prophylaxis Into Perspective

You'll hear buzz about Aimovig (AIM-oh-vig, erenumab), a new biologic to PREVENT migraines in adults.

It will be the first drug that blocks receptors for calcitonin gene-related peptide (CGRP)...a vasodilator and pain sensitizer that spikes during migraine attacks.

Aimovig may provide one or two fewer migraine days per month versus placebo. This seems similar to first-line oral meds for migraine prophylaxis...such as beta-blockers, topiramate, or valproate.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote